Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
GE HealthCare
Acquired Company
Sofie Biosciences
ChicagoCulver CityOtherInformation TechnologyBiotechnologyHealth CareMedicalBiotechnologyDescription
GE HealthCare is in advanced discussions to acquire Sofie Biosciences for approximately $1 billion. This acquisition aims to enhance GE HealthCare's offerings in radioactive diagnostic agents for medical imaging. The deal could significantly boost revenue potential by merging imaging equipment sales with diagnostic agents. The transaction may be announced soon, pending the outcome of ongoing negotiations.
Fundz sees it the moment GE HealthCare makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sofie Biosciences?
Sofie Biosciences was acquired by GE HealthCare, based in Chicago. The deal was reported on September 13, 2026. GE HealthCare is publicly traded (GEHC) and operates in Other.
When did GE HealthCare acquire Sofie Biosciences?
GE HealthCare's acquisition of Sofie Biosciences was reported on September 13, 2026. GE HealthCare is in advanced discussions to acquire Sofie Biosciences for approximately $1 billion. This acquisition aims to enhance GE HealthCare's offerings in radioactive diagnostic agents for medical imaging. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sofie Biosciences do?
Sofie Biosciences focuses on the development of radiopharmaceuticals for medical imaging. It operates a network that manufactures radioactive materials used in PET scans. The company's product pipeline includes agents for detecting cancers. It is privately held, operating in Biotechnology, and is based in Culver City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.